NCT06151054

Brief Summary

Show that there is a relationship between arterial stiffness and aortic parietal inflammation and that this relationship is different in the three age groups with aortic parietal inflammation occurring earlier than arterial stiffness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

October 30, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2022

Completed
12 months until next milestone

First Posted

Study publicly available on registry

November 30, 2023

Completed
Last Updated

November 30, 2023

Status Verified

November 1, 2023

Enrollment Period

1 month

First QC Date

September 8, 2022

Last Update Submit

November 28, 2023

Conditions

Arterial Stiffness

Outcome Measures

Primary Outcomes (1)

  • to etablish a relationship inflammation of aortic wall and arterial stiffness

    Standard Uptake Value

    1 day

Interventions

Measure of aortic inflammationDIAGNOSTIC_TEST

Standard Uptake Value (SUV) measures of aortic wall

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who underwent whole-body 18F-FDG PET/CT included in the PACTEP study and in this context, who had an assessment of arterial stiffness by applanation tonometer

You may qualify if:

  • Patients who underwent whole-body 18F-FDG PET/CT included in the PACTEP study
  • Patient with an assessment of arterial stiffness by applanation tonometer

You may not qualify if:

  • patients without an assessment of arterial stiffness by applanation tonometer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Nancy

Vandœuvre-lès-Nancy, 54511, France

Location

Study Officials

  • Anne-Sophie HUE, MSc

    CHRU Nancy

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

September 8, 2022

First Posted

November 30, 2023

Study Start

October 30, 2022

Primary Completion

November 30, 2022

Study Completion

December 6, 2022

Last Updated

November 30, 2023

Record last verified: 2023-11

Locations

FR(1)